Treatment of ADHD: Guanfacine Extended Release in ADHD
Investigators at Massachusetts General Hospital, Boston, MA, performed a multicenter, 9-week, double-blind, placebo-controlled, dose-optimization study of guanfacine extended release (GXR, <4 mg/d) adjunctive to a long-acting psychostimulant for ADHD continued in 461 subjects.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Pediatric Neurology Briefs Publishers,
2014-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Investigators at Massachusetts General Hospital, Boston, MA, performed a multicenter, 9-week, double-blind, placebo-controlled, dose-optimization study of guanfacine extended release (GXR, <4 mg/d) adjunctive to a long-acting psychostimulant for ADHD continued in 461 subjects. |
|---|---|
| Item Description: | 1043-3155 2166-6482 10.15844/pedneurbriefs-28-8s-8 |